Sriram Subramaniam, Gandeeva Therapeutics founder and CEO
January 31, 2022 08:23 AM ESTUpdated February 4, 01:42 AM
Financing

Cryo-EM fo­cused biotech from long­time NIH vet­er­an se­cures $40M back­ing from Bay­er in Se­ries A

Josh Sullivan

“It’s al­ways nice to get mon­ey in the bank.”

That’s what Gan­dee­va Ther­a­peu­tics’ founder and CEO Sri­ram Sub­ra­ma­ni­am said af­ter re­veal­ing that his com­pa­ny land­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times